Atara Biotherapeutics/ US0465131078 /

10/3/2023 7:37:08 PM	Chg. 0.00	Volume	Bid7:38:21 PM	Ask7:38:21 PM	High	Low
1.51USD	0.00%	9,184 Turnover: 13,603.57	1.50Bid Size: 400	1.51Ask Size: 100	1.52	1.45

Newsfile Corp 7/27/2022 ATRA INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible ...

GlobeNewswire 3/16/2022 C4 Therapeutics Appoints Utpal Koppikar to Board of Directors

GlobeNewswire 3/16/2022 Kither Biotech Raises €18.5 Million Series B and Appoints Dr. Vincent Metzler as Chief Executive Off...

GlobeNewswire 1/26/2022 Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Thera...

GlobeNewswire 11/3/2021 180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer

GlobeNewswire 10/12/2021 Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer

GlobeNewswire 7/12/2021 Flexion Therapeutics Announces Appointment of Utpal Koppikar to its Board of Directors

GlobeNewswire 6/14/2021 Certara Appoints Dr. Carol Gallagher as New Independent Board Member

GlobeNewswire 6/10/2021 Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

GlobeNewswire 6/1/2021 Derrell D. Porter, M.D., Elected to Board of Directors of Passage Bio

GlobeNewswire 4/13/2021 Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research

GlobeNewswire 2/5/2021 CareDx Showcases Cellular Transplantation and Therapy Portfolio at TCT

GlobeNewswire 10/21/2020 The Alliance for Regenerative Medicine Announces Election of 2021 Officers, Executive Committee, and...

GlobeNewswire 7/29/2020 The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2020 Cell & Gene...

GlobeNewswire 5/7/2020 Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Highlights

GlobeNewswire 4/6/2020 eGenesis Appoints David A. Carmel as Senior Vice President, Public Affairs and Communications

GlobeNewswire 2/27/2020 Atara Biotherapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Recent Clini...

GlobeNewswire 2/21/2020 Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire 2/20/2020 Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences

GlobeNewswire 2/19/2020 Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results on Thursday, F...

GlobeNewswire 2/13/2020 The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterra...

GlobeNewswire 2/5/2020 Atara Biotherapeutics Names Kristin Yarema as Chief Commercial Officer

GlobeNewswire 1/12/2020 Atara Biotherapeutics to Present 2020 Key Milestones and Progress in Bringing Off-The-Shelf, Allogen...

GlobeNewswire 12/11/2019 The Alliance for Regenerative Medicine Announces 2020 Cell & Gene Therapies State of the Industry Br...

GlobeNewswire 12/9/2019 Atara Biotherapeutics Reports Updated Long-Term Clinical Results from a Tab-cel® Multicenter Expande...